RETRACTED: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients - Wikidata - awgldk - TriplyDB

RETRACTED: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients

RETRACTED: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients

http://www.wikidata.org/entity/Q37267763

about

Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade The impact of chronic stress on the rat brain lipidome Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review How Schizophrenia Develops: Cognitive and Brain Mechanisms Underlying Onset of Psychosis Inflammation and the two-hit hypothesis of schizophrenia.Brain imaging during the transition from psychosis prodrome to schizophrenia.Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies.Developmental exposure to concentrated ambient ultrafine particulate matter air pollution in mice results in persistent and sex-dependent behavioral neurotoxicity and glial activation.Coordinated gene expression of neuroinflammatory and cell signaling markers in dorsolateral prefrontal cortex during human brain development and aging.Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk.Analysis of schizophrenia and hepatocellular carcinoma genetic network with corresponding modularity and pathways: novel insights to the immune system Is schizophrenia a neurodegenerative disease? Evidence from age-related decline of brain-derived neurotrophic factor in the brains of schizophrenia patients and matched nonpsychiatric controls.The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies.Pro-/antiinflammatory dysregulation in early psychosis: results from a 1-year follow-up study.ZNF804A Transcriptional Networks in Differentiating Neurons Derived from Induced Pluripotent Stem Cells of Human Origin Brain in flames - animal models of psychosis: utility and limitations Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study.Microglial activation and progressive brain changes in schizophrenia.Levels of Red Blood Cell Fatty Acids in Patients With Psychosis, Their Unaffected Siblings, and Healthy Controls Eicosanoids Derived From Arachidonic Acid and Their Family Prostaglandins and Cyclooxygenase in Psychiatric Disorders Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia.Brain Biomarkers of Vulnerability and Progression to Psychosis Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia?Neuropathology of cigarette smoking.The neurobiology and treatment of first-episode schizophrenia.Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms.Transcriptome-wide mega-analyses reveal joint dysregulation of immunologic genes and transcription regulators in brain and blood in schizophrenia.Dysregulations of Synaptic Vesicle Trafficking in Schizophrenia The role of drebrin in neurons.Changed gene expression in subjects with schizophrenia and low cortical muscarinic M1 receptors predicts disrupted upstream pathways interacting with that receptor.Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain.Differences in omega-3 and omega-6 polyunsaturated fatty acid consumption in people at ultra-high risk of psychosis, first-episode schizophrenia, and in healthy controls.Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia.Increased expression of astrocyte markers in schizophrenia: Association with neuroinflammation.Microglia and Brain Plasticity in Acute Psychosis and Schizophrenia Illness Course: A Meta-Review.Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications.Characterization of Behavioral, Signaling and Cytokine Alterations in a Rat Neurodevelopmental Model for Schizophrenia, and Their Reversal by the 5-HT6 Receptor Antagonist SB-399885.

P2860

Q26782867-84B6447C-6C4C-4FB7-9AE5-606B1C4A957B Q26850084-AB2C2863-0B86-456B-BB07-5AC122E353D5 Q27319840-19015E35-4758-437B-9C76-F160D919A4F7 Q28077391-41150DFE-0983-4FE1-9999-4F0486A2C546 Q28087255-FD0BA38B-B01E-43B2-9501-53524D94D575 Q30422062-A1E3BE4E-76A8-4664-97ED-67095A221FDD Q30938447-D10561A7-0F19-487C-B97B-8B968C89DEEA Q33601896-687EA6FB-C1DB-413B-8EB4-C5A268D8E218 Q33845281-9EA09B4E-97B4-46E7-9F38-9F888B724CAC Q34374526-161642C6-8255-44F1-AAF0-903F649B87BB Q34691699-8B7529B5-4CAB-41D9-A508-A365F3CFFE0D Q35101267-9B08E23C-06C2-4BD2-B389-A589787E74C2 Q35143317-FBFBD2BB-05F9-4C94-91D3-4E5813205BBF Q35186635-8A0FF4D9-C9F2-4321-8F27-629D7BB07FED Q35203663-7D6CED23-AF9C-4B4F-A6F4-154426B5AC1F Q35533016-4AB7013F-95D7-4CDB-8E4B-315A918CE8EE Q35683865-71F1971A-5B3A-4342-B22F-ACBC2472C366 Q36113742-5824AF8F-DA88-4458-8FEE-1865F63E493F Q36546971-F8069D35-6D77-4C6B-BF46-BC58C6813E24 Q36580009-F8FA7966-2D57-4607-BFF7-6BE7CF8CCF3C Q36594940-1B8060F6-9D69-49C3-AB80-912CE34B6738 Q36858447-5AA2D6E9-FE1E-4B00-A4E1-0B814CCA556D Q37124940-77169274-8FC0-494A-BFFE-FADEA2E70BD2 Q37429365-03B5E161-BD73-4A35-BDB9-55536A693115 Q37721268-DC8CF08D-B360-4F22-B059-90E2D9331E98 Q38163337-FBE0896F-1680-41A2-BBB1-C40551A1940F Q38232366-EE368520-25C5-4786-86D5-E89811C309DB Q38805367-D42E8239-DA5E-4F74-A0CE-5245F4927840 Q38838480-EC7BBDF3-84BF-4493-8A09-D0223EC41FFF Q38883878-DEEEAFB9-4F8A-44DB-BD4E-70AAC3562C64 Q38960458-FFA7D0D3-BD13-4B13-B792-63B85D821389 Q39227633-18153602-F36A-43B8-BD9C-51A8278F2450 Q39938122-8BE361C1-5D25-473F-A9CA-7AE5304E0675 Q41477685-B423E911-047D-493C-B3EE-75DBB07B8C66 Q41611297-F8BA2445-E136-4D38-9BA1-D6DA6752C50C Q41687400-9141437E-9ECC-4C5C-87B7-F152A27FEFBB Q42774951-95854D51-FFDB-4219-AB95-98678BB718B3 Q47152736-91901824-D07B-4D68-8238-1FAE1E68294F Q48507006-99049CA1-B8B5-4F13-80F0-CCA3DB50FBB2 Q50052167-81266E58-B8B7-48CE-AD04-ABBA220F217D

P2860

RETRACTED: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients

http://www.wikidata.org/entity/Q37267763

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 April 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

RETRACTED: Increased neuroinfl ...... ex from schizophrenia patients

@en

RETRACTED: Increased neuroinfl ...... x from schizophrenia patients.

@nl

type

label

RETRACTED: Increased neuroinfl ...... ex from schizophrenia patients

@en

RETRACTED: Increased neuroinfl ...... x from schizophrenia patients.

@nl

prefLabel

RETRACTED: Increased neuroinfl ...... ex from schizophrenia patients

@en

RETRACTED: Increased neuroinfl ...... x from schizophrenia patients.

@nl

P1433

Q37267763-47CACD15-2BCE-4D0A-9C9A-8849DBEE2AC7

P1476

Q37267763-B9064A5B-8464-4FC8-9D7E-1CC1CE15B2A6

P2093

Q37267763-05423276-A009-4DDB-A8D4-CEF308C70240

Q37267763-0AFC72CA-36D9-4702-A2E8-16570CEEC3E2

Q37267763-423EFDE2-6AEE-492C-A0CF-4A9547AC56A3

Q37267763-78609FCB-C11E-4C4C-8B78-D2D4ED76DABD

Q37267763-C0ED67E1-2442-4236-B10E-0E69C401CAF0

P2860

Q37267763-05AA9DDD-4E66-4355-84E2-9CCF27069868

Q37267763-0F9BF818-724A-4B32-A6E0-8656E691A710

Q37267763-19B8C4E7-D20D-462B-BA79-54ECAE47E874

Q37267763-309C31BB-BF15-4356-AD4F-53AE4AC2B355

Q37267763-30A79AF4-E16F-4B0F-97D1-58F04846B3B3

Q37267763-347B5C80-41EB-4408-8D23-3B285BDECC03

Q37267763-347E5AE5-5321-469B-AEDD-0A92CD389DBD

Q37267763-37535603-5566-44A7-8A5A-D0ED89BD3145

Q37267763-3C382456-8E9F-4CDF-85C9-EED4311218CA

Q37267763-3F0308B4-0650-45FE-A74D-43BECC75F04D

P304

Q37267763-86D45DD2-6219-401B-8C31-EF88661865EF

P31

Q37267763-4F783C77-13F8-4C37-8086-5E06180D96E8

P356

Q37267763-9AEC176E-EC77-4C98-B15E-50F845F35157

P407

Q37267763-7F11E350-9B05-41E9-A901-AAA802CF2E4B

P433

Q37267763-4B071291-99BD-42AB-BF59-252EF17BE5DF

P478

Q37267763-16CC6EEF-1D36-443A-86FB-E59244AF7AB5

P577

Q37267763-5D13ACC3-7972-4D86-9664-00F71EB3AFDA

P698

Q37267763-7C6FCB13-0451-46AE-8936-D57F39302823

P921

Q37267763-07D5FF63-8EE0-425A-8263-61D16C75FECE

Q37267763-3490C1E1-E41D-4509-B8F2-97939DBD97B5

P932

Q37267763-0A4DDAAA-1A8F-4225-AB2C-DF5B24EEFD0D

P356

J.SCHRES.2013.02.017

P1433

Schizophrenia Research

P1476

RETRACTED: Increased neuroinfl ...... ex from schizophrenia patients

@en

P2093

Edmund Arthur Reese

http://www.w3.org/2001/XMLSchema#string

Gaylia Jean Harry

http://www.w3.org/2001/XMLSchema#string

Hyung-Wook Kim

http://www.w3.org/2001/XMLSchema#string

Jagadeesh Sridhara Rao

http://www.w3.org/2001/XMLSchema#string

Stanley Isaac Rapoport

http://www.w3.org/2001/XMLSchema#string

P2860

Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Immunocytochemical demonstration of rod-opsin, S-antigen, and neuron-specific proteins in the human pineal gland

Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial

Disappearance of actin-binding protein, drebrin, from hippocampal synapses in Alzheimer's disease

Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease

Drebrin A is a postsynaptic protein that localizes in vivo to the submembranous surface of dendritic sites forming excitatory synapses

Brain pathology in first-episode psychosis: magnetization transfer imaging provides additional information to MRI measurements of volume loss.

Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients.

Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients.

P304

24-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SCHRES.2013.02.017

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

147

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23566496

http://www.w3.org/2001/XMLSchema#string

P921

P932

3812915

http://www.w3.org/2001/XMLSchema#string